NEOADJUVANT FOR PATIENTS WITH HIGH AND VERY HIGH RISK PROSTATE CANCER. Вопр. онкол. [Internet]. 2019 May 1 [cited 2026 Oct. 14];65(5):726-35. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/1021